Winolap DS Eye Drop contains Olopatadine 0.2% w/v, a selective histamine H1 receptor antagonist with potent anti-allergic and anti-inflammatory properties. It is indicated for the treatment of allergic conjunctivitis, providing rapid relief from symptoms such as itching, redness, swelling, and watery eyes. Olopatadine acts by inhibiting the release of histamine and other mediators from mast cells, thereby preventing the cascade of allergic reactions in the ocular tissues. The 0.2% concentration ensures effective symptom control with a convenient twice-daily dosing regimen. Winolap DS Eye Drop is suitable for adults and pediatric patients aged 3 years and above. It is generally well tolerated, with minimal systemic absorption reducing the risk of systemic side effects. Common adverse reactions may include transient burning or stinging upon instillation, mild dry eyes, or headache. Caution is advised in patients with hypersensitivity to Olopatadine or any component of the formulation. It is recommended to avoid contact lens use during treatment unless otherwise directed by a healthcare professional. Winolap DS Eye Drop offers a safe and effective therapeutic option for managing allergic conjunctivitis, improving patient comfort and quality of life through targeted ocular allergy relief.